Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial Results
January 22, 2016 9:22 AM EST
Leerink Partners maintained a Market Perform rating on Cardiovascular Systems (NASDAQ: CSII), and cut the price target to $13.00 (from $17.00), following the company's 2Q earnings report. For F2Q16, CSII reported sales of $41.4M, ~$2M below consensus. Also, management guided F3Q16 revenues well below consensus, yet again, at $40.5M-$42.0M vs. the Street at $46.1M. The guidance indicated what appears to be a more protracted impact than originally expected from the ongoing... More
January 22, 2016 7:34 AM EST
Needham & Company downgraded Cardiovascular Systems (NASDAQ: CSII) from Buy to Underperform, saying positive revenue growth may be a year away.
Analyst Mike Matson commented, "CSII's F2Q16 revenue missed and EPS beat consensus and management guided below consensus for F2Q16. We are... More
January 21, 2016 4:15 PM EST
Cardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.47), $0.03 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $41.4 million versus the consensus estimate of $44.82 million.
GUIDANCE:
Cardiovascular Systems sees Q3 2016 EPS of ($0.42)-($0.45), versus the consensus of ($0.45).... More
